Nasdaq · CIK 0001232524
JAZZ Jazz Pharmaceuticals plc
Insider trading from SEC Form 4. Last filing 5 d ago. Close $218.42 on Oct 9, 2026, +67% from the 52-week low and -17% from the high.
Last 90 days
Net insider value
-$4.1M
more sold than bought
Buys
0
$0 by 0 insiders
Sells
5
$4.1M by 3 insiders
Insiders on file
18
with a Form 4 at this company
Price and insider trades, last year
JAZZOct 9, 2026 · close 218.42
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Jazz Pharmaceuticals plc, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Renee D Gala President & CEO sell | $473k 2,000 shares | -1% | +76% from low-12% from high | |
| 28Weak | Bruce C Cozadd Chairman & CEO sell | $1.4M 6,000 shares | -2% | +78% from low-11% from high | |
| 24Weak | Neena M Patil EVP & Chief Legal Officer sell | $289k 1,200 shares | -2% | - | |
| 38Weak | Renee D Gala President & CEO sell | $486k 2,000 shares | -1% | - | |
| 45Moderate | Bruce C Cozadd Chairman & CEO sell | $1.5M 6,000 shares | -2% | - | |
| 17Weak | Bruce C Cozadd Chairman & CEO sell | $772k 6,000 shares | -1% | +33% from low-10% from high | |
| 15Weak | Bruce C Cozadd Chairman & CEO sell | $113k 1,000 shares | -0% | +18% from low-20% from high | |
| 15Weak | Bruce C Cozadd Chairman & CEO sell | $108k 1,000 shares | -0% | +12% from low-24% from high | |
| 15Weak | Bruce C Cozadd Chairman & CEO sell | $109k 1,000 shares | -0% | +11% from low-25% from high | |
| 66Notable | Seamus Mulligan director buy | $10.0M 101,621 shares | - | 0% from low-32% from high | |
| 17Weak | Bruce C Cozadd Chairman & CEO sell | $176k 1,500 shares | -0% | +17% from low-19% from high | |
| 17Weak | Bruce C Cozadd Chairman & CEO sell | $186k 1,500 shares | -0% | +19% from low-13% from high | |
| 45Moderate | Robert Iannone EVP, Global Head of R&D & CMO sell | $333k 2,403 shares | -3% | - | |
| 46Moderate | Patricia Carr SVP, Chief Accounting Officer sell | $157k 1,140 shares | -14% | - | |
| 35Weak | Robert Iannone EVP, Global Head of R&D & CMO sell | $981k 7,080 shares | -8% | - | |
| 44Moderate | Bruce C Cozadd Chairman & CEO sell | $938k 6,500 shares | -1% | - | |
| 47Moderate | Patricia Carr SVP, Chief Accounting Officer sell | $806k 5,586 shares | -44% | - | |
| 54Moderate | Neena M Patil EVP & Chief Legal Officer sell | $551k 3,800 shares | -10% | - | |
| 17Weak | Bruce C Cozadd Chairman & CEO sell | $183k 1,500 shares | -0% | - | |
| 17Weak | Bruce C Cozadd Chairman & CEO sell | $185k 1,500 shares | -0% | - | |
| 26Weak | Bruce C Cozadd Chairman & CEO sell | $242k 2,000 shares | -0% | - | |
| 23Weak | Patricia Carr SVP, Chief Accounting Officer sell | $6,492 53 shares | -1% | - | |
| 45Moderate | Neena M Patil EVP & Chief Legal Officer sell | $457k 3,700 shares | -10% | - | |
| 23Weak | Bruce C Cozadd Chairman & CEO sell | $111k 1,000 shares | -0% | - |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Renee D Gala President & CEO | SOpen-market sale Ordinary Shares10b5-1 | -2,000 | $236.40 | $473k | 141,394 | 5 d ago |
| Oct 1, 2026 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -6,000 | $230.33 | $1.4M | 345,875 | 7 d ago |
| Sep 10, 2026 | Neena M Patil EVP & Chief Legal Officer | SOpen-market sale Ordinary Shares10b5-1 | -1,200 | $240.94 | $289k | 47,671 | 28 d ago |
| Sep 8, 2026 | Renee D Gala President & CEO | FTax withholding Ordinary Shares10b5-1 | -1,967 | $246.81 | $485k | 145,394 | 32 d ago |
| Sep 8, 2026 | Mary Elizabeth Henderson SVP, Technical Operations | FTax withholding Ordinary Shares | -1,412 | $243.03 | $343k | 23,830 | 32 d ago |
| Sep 8, 2026 | Mary Elizabeth Henderson SVP, Technical Operations | FTax withholding Ordinary Shares | -15 | $241.20 | $3,618 | 23,815 | 32 d ago |
| Sep 8, 2026 | Renee D Gala President & CEO | SOpen-market sale Ordinary Shares10b5-1 | -2,000 | $243.03 | $486k | 143,394 | 32 d ago |
| Aug 31, 2026 | Mary Elizabeth Henderson SVP, Technical Operations | FTax withholding Ordinary Shares | -2,076 | $241.39 | $501k | 25,258 | 40 d ago |
| Aug 31, 2026 | Ted W Love director | FTax withholding Ordinary Shares | -6 | $244.06 | $1,464 | 3,126 | 40 d ago |
| Aug 31, 2026 | Jennifer E. Cook director | FTax withholding Ordinary Shares | -14 | $244.06 | $3,417 | 12,428 | 40 d ago |
| Aug 31, 2026 | Bruce C Cozadd Chairman & CEO | FTax withholding Ordinary Shares10b5-1 | -10 | $244.06 | $2,441 | 359,084 | 40 d ago |
| Aug 31, 2026 | Rick E Winningham director | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 9,480 | 40 d ago |
| Aug 31, 2026 | Heather Ann McSharry director | FTax withholding Ordinary Shares | -15 | $244.64 | $3,670 | 20,039 | 40 d ago |
| Aug 31, 2026 | Patrick G Enright director | FTax withholding Ordinary Shares | -14 | $244.64 | $3,425 | 22,970 | 40 d ago |
| Aug 31, 2026 | Mark Douglas Smith director | FTax withholding Ordinary Shares | -14 | $244.64 | $3,425 | 11,271 | 40 d ago |
| Aug 31, 2026 | Patrick Kennedy director | FTax withholding Ordinary Shares | -15 | $244.06 | $3,661 | 8,292 | 40 d ago |
| Aug 31, 2026 | Norbert G Riedel director | FTax withholding Ordinary Shares | -14 | $244.64 | $3,425 | 8,615 | 40 d ago |
| Aug 31, 2026 | Laura Hamill director | FTax withholding Ordinary Shares | -14 | $244.06 | $3,417 | 8,524 | 40 d ago |
| Aug 31, 2026 | Laura Hamill director | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 6,832 | 40 d ago |
| Aug 31, 2026 | Bruce C Cozadd Chairman & CEO | FTax withholding Ordinary Shares10b5-1 | -1,209 | $241.39 | $292k | 357,875 | 40 d ago |
| Aug 31, 2026 | Mary Elizabeth Henderson SVP, Technical Operations | FTax withholding Ordinary Shares | -16 | $244.64 | $3,914 | 25,242 | 40 d ago |
| Aug 31, 2026 | Norbert G Riedel director | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 6,923 | 40 d ago |
| Aug 31, 2026 | Rick E Winningham director | FTax withholding Ordinary Shares | -14 | $244.64 | $3,425 | 9,466 | 40 d ago |
| Aug 31, 2026 | Ted W Love director | FTax withholding Ordinary Shares | -737 | $241.39 | $178k | 2,389 | 40 d ago |
| Aug 31, 2026 | Jennifer E. Cook director | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 10,736 | 40 d ago |
| Aug 31, 2026 | Heather Ann McSharry director | FTax withholding Ordinary Shares | -1,840 | $241.39 | $444k | 18,199 | 40 d ago |
| Aug 31, 2026 | Mark Douglas Smith director | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 9,579 | 40 d ago |
| Aug 31, 2026 | Patrick G Enright director | FTax withholding Ordinary Shares | -1,692 | $241.39 | $408k | 21,278 | 40 d ago |
| Aug 31, 2026 | Patrick Kennedy director | FTax withholding Ordinary Shares | -1,840 | $241.39 | $444k | 6,452 | 40 d ago |
| Sep 1, 2026 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -6,000 | $250.13 | $1.5M | 351,875 | 40 d ago |
| Sep 14, 2025 | Bruce C Cozadd Chairman & CEO | FTax withholding Ordinary Shares | -15,647 | $126.16 | $2.0M | 414,326 | Sep 17, 2025 |
| Sep 2, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -3,000 | $127.23 | $382k | 432,973 | Sep 4, 2025 |
| Sep 2, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -3,000 | $130.00 | $390k | 429,973 | Sep 4, 2025 |
| Aug 7, 2025 | Jennifer E. Cook director | AGrant or award Ordinary Shares | +3,507 | $0.00 | $0 | 12,642 | Aug 11, 2025 |
| Aug 7, 2025 | Patrick G Enright director | AGrant or award Ordinary Shares | +3,507 | $0.00 | $0 | 28,184 | Aug 11, 2025 |
| Aug 7, 2025 | Renee D Gala President & CEO | AGrant or award Ordinary Shares | +18,808 | $0.00 | $0 | 107,869 | Aug 11, 2025 |
| Aug 8, 2025 | Jennifer E. Cook director | FTax withholding Ordinary Shares | -1,805 | $111.25 | $201k | 10,837 | Aug 11, 2025 |
| Aug 8, 2025 | Patrick G Enright director | FTax withholding Ordinary Shares | -1,805 | $111.25 | $201k | 26,379 | Aug 11, 2025 |
| Aug 1, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -1,000 | $113.21 | $113k | 435,973 | Aug 5, 2025 |
| Jul 1, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -500 | $105.26 | $53k | 437,473 | Jul 3, 2025 |
| Jul 1, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -500 | $110.00 | $55k | 436,973 | Jul 3, 2025 |
| Jun 2, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -500 | $107.90 | $54k | 438,473 | Jun 4, 2025 |
| Jun 3, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -500 | $110.00 | $55k | 437,973 | Jun 4, 2025 |
| May 9, 2025 | Seamus Mulligan director | POpen-market purchase Ordinary Sharesindirect: By Nerano Pharma Lim | +80,684 | $98.10 | $7.9M | 80,684 | May 13, 2025 |
| May 9, 2025 | Seamus Mulligan director | POpen-market purchase Ordinary Sharesindirect: By Nerano Pharma Lim | +19,216 | $98.91 | $1.9M | 99,900 | May 13, 2025 |
| May 9, 2025 | Seamus Mulligan director | POpen-market purchase Ordinary Sharesindirect: By Nerano Pharma Lim | +100 | $99.71 | $9,971 | 100,000 | May 13, 2025 |
| May 12, 2025 | Seamus Mulligan director | POpen-market purchase Ordinary Sharesindirect: By Nerano Pharma Lim | +1,621 | $103.00 | $167k | 101,621 | May 13, 2025 |
| May 1, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -1,000 | $116.35 | $116k | 439,307 | May 5, 2025 |
| May 2, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -500 | $120.00 | $60k | 438,807 | May 5, 2025 |
| Apr 1, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -1,500 | $123.75 | $186k | 440,307 | Apr 3, 2025 |
| Mar 10, 2025 | Robert Iannone EVP, Global Head of R&D & CMO | SOpen-market sale Ordinary Shares | -2,403 | $138.41 | $333k | 79,621 | Mar 12, 2025 |
| Mar 7, 2025 | Patricia Carr SVP, Chief Accounting Officer | DDisposition to issuer Ordinary Shares | -1,333 | $138.23 | $184k | 8,152 | Mar 11, 2025 |
| Mar 7, 2025 | Mary Elizabeth Henderson SVP, Technical Operations | DDisposition to issuer Ordinary Shares | -698 | $138.23 | $96k | 23,077 | Mar 11, 2025 |
| Mar 10, 2025 | Patricia Carr SVP, Chief Accounting Officer | SOpen-market sale Ordinary Shares | -1,140 | $137.81 | $157k | 7,012 | Mar 11, 2025 |
| Mar 5, 2025 | Bruce C Cozadd Chairman & CEO | DDisposition to issuer Ordinary Shares | -22,251 | $138.95 | $3.1M | 441,807 | Mar 7, 2025 |
| Mar 5, 2025 | Renee D Gala President & COO | DDisposition to issuer Ordinary Shares | -5,704 | $138.95 | $793k | 88,895 | Mar 7, 2025 |
| Mar 5, 2025 | Robert Iannone EVP, Global Head of R&D & CMO | DDisposition to issuer Ordinary Shares10b5-1 | -5,239 | $138.95 | $728k | 89,104 | Mar 7, 2025 |
| Mar 5, 2025 | Philip L Johnson EVP & Chief Financial Officer | DDisposition to issuer Ordinary Shares | -1,149 | $138.95 | $160k | 50,060 | Mar 7, 2025 |
| Mar 5, 2025 | Neena M Patil EVP & Chief Legal Officer | DDisposition to issuer Ordinary Shares | -4,088 | $138.95 | $568k | 47,526 | Mar 7, 2025 |
| Mar 5, 2025 | Samantha Pearce EVP, Chief Commercial Officer | DDisposition to issuer Ordinary Shares | -1,905 | $138.95 | $265k | 41,226 | Mar 7, 2025 |
| Mar 7, 2025 | Robert Iannone EVP, Global Head of R&D & CMO | SOpen-market sale Ordinary Shares10b5-1 | -5,532 | $138.21 | $765k | 83,572 | Mar 7, 2025 |
| Mar 7, 2025 | Robert Iannone EVP, Global Head of R&D & CMO | SOpen-market sale Ordinary Shares10b5-1 | -1,548 | $140.00 | $217k | 82,024 | Mar 7, 2025 |
| Feb 27, 2025 | Bruce C Cozadd Chairman & CEO | AGrant or award Ordinary Shares10b5-1 | +30,814 | $0.00 | $0 | 470,558 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | MOption exercise Ordinary Shares | +4,500 | $113.10 | $509k | 12,737 | Mar 3, 2025 |
| Feb 27, 2025 | Renee D Gala President & COO | AGrant or award Ordinary Shares | +23,111 | $0.00 | $0 | 83,044 | Mar 3, 2025 |
| Feb 27, 2025 | Mary Elizabeth Henderson SVP, Technical Operations | AGrant or award Ordinary Shares | +5,392 | $0.00 | $0 | 19,923 | Mar 3, 2025 |
| Feb 27, 2025 | Neena M Patil EVP & Chief Legal Officer | SOpen-market sale Ordinary Shares | -3,800 | $144.87 | $551k | 33,318 | Mar 3, 2025 |
| Feb 27, 2025 | Robert Iannone EVP, G R&D and CMO | AGrant or award Ordinary Shares | +17,718 | $0.00 | $0 | 85,484 | Mar 3, 2025 |
| Feb 27, 2025 | Philip L Johnson EVP & Chief Financial Officer | AGrant or award Ordinary Shares | +15,407 | $0.00 | $0 | 43,505 | Mar 3, 2025 |
| Feb 27, 2025 | Samantha Pearce EVP, Chief Commercial Officer | AGrant or award Ordinary Shares | +11,941 | $0.00 | $0 | 37,353 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | SOpen-market sale Ordinary Shares | -4,500 | $144.42 | $650k | 8,237 | Mar 3, 2025 |
| Feb 27, 2025 | Renee D Gala President & COO | AGrant or award Ordinary Shares | +11,555 | $0.00 | $0 | 94,599 | Mar 3, 2025 |
| Feb 27, 2025 | Mary Elizabeth Henderson SVP, Technical Operations | AGrant or award Ordinary Shares | +3,852 | $0.00 | $0 | 23,775 | Mar 3, 2025 |
| Feb 27, 2025 | Robert Iannone EVP, G R&D and CMO | AGrant or award Ordinary Shares | +8,859 | $0.00 | $0 | 94,343 | Mar 3, 2025 |
| Feb 27, 2025 | Neena M Patil EVP & Chief Legal Officer | AGrant or award Ordinary Shares | +12,518 | $0.00 | $0 | 45,836 | Mar 3, 2025 |
| Feb 27, 2025 | Philip L Johnson EVP & Chief Financial Officer | AGrant or award Ordinary Shares | +7,704 | $0.00 | $0 | 51,209 | Mar 3, 2025 |
| Feb 27, 2025 | Samantha Pearce EVP, Chief Commercial Officer | AGrant or award Ordinary Shares | +5,778 | $0.00 | $0 | 43,131 | Mar 3, 2025 |
| Mar 3, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -6,500 | $144.25 | $938k | 464,058 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | MOption exercise Ordinary Shares | +313 | $123.36 | $39k | 8,550 | Mar 3, 2025 |
| Feb 27, 2025 | Neena M Patil EVP & Chief Legal Officer | AGrant or award Ordinary Shares | +5,778 | $0.00 | $0 | 51,614 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | SOpen-market sale Ordinary Shares | -313 | $144.42 | $45k | 8,237 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | DDisposition to issuer Ordinary Shares | -371 | $142.43 | $53k | 7,866 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | DDisposition to issuer Ordinary Shares | -497 | $142.43 | $71k | 7,369 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | AGrant or award Ordinary Shares | +2,889 | $0.00 | $0 | 10,258 | Mar 3, 2025 |
| Feb 28, 2025 | Patricia Carr SVP, Chief Accounting Officer | SOpen-market sale Ordinary Shares | -773 | $143.30 | $111k | 9,485 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -4,500 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 27, 2025 | Patricia Carr SVP, Chief Accounting Officer | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -313 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 3, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -1,500 | $122.31 | $183k | 439,744 | Feb 5, 2025 |
| Jan 17, 2025 | Bruce C Cozadd Chairman & CEO | AGrant or award Ordinary Shares | +29,559 | $0.00 | $0 | 455,084 | Jan 22, 2025 |
| Jan 17, 2025 | Patricia Carr SVP, Chief Accounting Officer | AGrant or award Ordinary Shares | +1,641 | $0.00 | $0 | 8,237 | Jan 22, 2025 |
| Jan 17, 2025 | Renee D Gala President & COO | AGrant or award Ordinary Shares | +7,741 | $0.00 | $0 | 63,233 | Jan 22, 2025 |
| Jan 17, 2025 | Robert Iannone EVP, G R&D and CMO | AGrant or award Ordinary Shares | +7,506 | $0.00 | $0 | 69,947 | Jan 22, 2025 |
| Jan 17, 2025 | Samantha Pearce EVP, Chief Commercial Officer | AGrant or award Ordinary Shares | +2,533 | $0.00 | $0 | 26,777 | Jan 22, 2025 |
| Jan 17, 2025 | Neena M Patil EVP & Chief Legal Officer | AGrant or award Ordinary Shares | +5,864 | $0.00 | $0 | 39,023 | Jan 22, 2025 |
| Jan 17, 2025 | Bruce C Cozadd Chairman & CEO | FTax withholding Ordinary Shares | -13,840 | $122.62 | $1.7M | 441,244 | Jan 22, 2025 |
| Jan 17, 2025 | Renee D Gala President & COO | FTax withholding Ordinary Shares | -3,300 | $122.62 | $405k | 59,933 | Jan 22, 2025 |
| Jan 17, 2025 | Robert Iannone EVP, G R&D and CMO | FTax withholding Ordinary Shares | -2,181 | $122.62 | $267k | 67,766 | Jan 22, 2025 |
| Jan 17, 2025 | Samantha Pearce EVP, Chief Commercial Officer | FTax withholding Ordinary Shares | -1,365 | $122.62 | $167k | 25,412 | Jan 22, 2025 |
| Jan 17, 2025 | Neena M Patil EVP & Chief Legal Officer | FTax withholding Ordinary Shares | -1,905 | $122.62 | $234k | 37,118 | Jan 22, 2025 |
| Jan 2, 2025 | Bruce C Cozadd Chairman & CEO | SOpen-market sale Ordinary Shares10b5-1 | -1,500 | $123.43 | $185k | 425,525 | Jan 6, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Bruce C CozaddChairman & CEO
- Patricia CarrSVP, Chief Accounting Officer
- Jennifer E. Cookdirector
- Patrick G Enrightdirector
- Renee D GalaPresident & CEO
- Laura Hamilldirector
- Mary Elizabeth HendersonSVP, Technical Operations
- Robert IannoneEVP, Global Head of R&D & CMO
- Philip L JohnsonEVP & Chief Financial Officer
- Patrick Kennedydirector
- Ted W Lovedirector
- Heather Ann McSharrydirector
- Seamus Mulligandirector
- Neena M PatilEVP & Chief Legal Officer
- Samantha PearceEVP, Chief Commercial Officer
- Norbert G Riedeldirector
- Mark Douglas Smithdirector
- Rick E Winninghamceo, officer, director
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.